Announcements Trials

Browse Landscape

Phase

Phase NA 13 Phase 1 12 Phase 1/2 7 Phase 3 1 Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 555 Carcinoma, Non-Small-Cell Lung 507 Prostatic Neoplasms 330 Neoplasms 268 Multiple Myeloma 266 Colorectal Neoplasms 264 Leukemia, Myeloid, Acute 225 Squamous Cell Carcinoma of Head and Neck 216 Lung Neoplasms 209 Neoplasm Metastasis 203 Carcinoma, Hepatocellular 195 Triple Negative Breast Neoplasms 172 Melanoma 172 Pancreatic Neoplasms 170 Ovarian Neoplasms 150 Recurrence 148 Lymphoma 143 Glioblastoma 134 Brain Neoplasms 133 Sarcoma 128 Leukemia, Lymphocytic, Chronic, B-Cell 127 Carcinoma, Renal Cell 127 Lymphoma, Large B-Cell, Diffuse 125 Stomach Neoplasms 124 Head and Neck Neoplasms 120 Precursor Cell Lymphoblastic Leukemia-Lymphoma 110 Rectal Neoplasms 107 Myelodysplastic Syndromes 105 Urinary Bladder Neoplasms 100 Small Cell Lung Carcinoma 98

Interventions

Trastuzumab 1 IFL protocol 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Advanced Cancer × 1 year × Clear all

NCT05605509 2026-02-06

RP-6306 in Patients With Advanced Cancer

Canadian Cancer Trials Group

Phase 2 Completed

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡